Amgen - PDFSEARCH.IO - Document Search Engine

Amgen
Results: 561

#	Item
361	Questions for October 18, 2010 Cardiovascular and Renal Drugs Advisory Committee Meeting Add to Reading List Source URL: www.fda.gov Language: English Biology Anatomy Organ failure Amgen Erythropoietin Darbepoetin alfa Chronic kidney disease Renal failure Anemia Medicine Erythropoiesis-stimulating agents Growth factors
362	PRODUCT MONOGRAPH Prolia Pr (denosumab) Add to Reading List Source URL: www.amgen.ca Language: English - Date: 2014-07-03 07:23:15 Amgen Denosumab Bisphosphonates Drugs Osteoporosis Osteonecrosis of the jaw Aromatase inhibitor Hypovitaminosis D Hip fracture Medicine Health Pharmacology
363	Microsoft Word[removed]Epogen-Procrit ED Ltr.doc Add to Reading List Source URL: www.fda.gov Language: English Amgen Erythropoietin Biology Pharmacology Package insert Medicine Erythropoiesis-stimulating agents Growth factors
364	Pediatric Focused Safety Review: pegfilgrastim (Neulasta) Add to Reading List Source URL: www.fda.gov Language: English Piperazines Clinical pharmacology Food and Drug Administration Pharmacology Therapeutics United States Public Health Service Amgen Febrile neutropenia Medicine Health Pharmaceutical sciences
365	Department of Health and Human Services Public Health Service Food and Drug-Administration Center for Drug Evaluation and Research Add to Reading List Source URL: www.fda.gov Language: English Amgen Hematopoietic stem cell transplantation Myelodysplastic syndrome Neutropenia Aplastic anemia Pharmacist Methadone Pharmacy Medical prescription Medicine Health Pegfilgrastim
366	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Vectibix safely and effectively. See full prescribing information for Vectibix. ---------------------DOSAGE FORMS AN Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-08-20 14:33:43 Chemotherapy Amgen Colorectal cancer Adverse effect FOLFOX Cetuximab Medicine Panitumumab KRAS
367	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use XGEVA® safely and effectively. See full prescribing information for XGEVA. Xgeva (denosumab) injection, for subcuta Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-06-13 10:38:35 Denosumab Zoledronic acid Giant-cell tumor of bone Osteonecrosis of the jaw Osteoprotegerin Multiple myeloma Chemotherapy Alendronic acid Medicine Bisphosphonates Amgen
368	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Vectibix safely and effectively. See full prescribing information for Vectibix. ---------------------DOSAGE FORMS AN Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-04-01 15:23:39 Chemotherapy Amgen Colorectal cancer Adverse effect FOLFOX Cetuximab Medicine Panitumumab KRAS
369	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Epogen safely and effectively. See full prescribing information for Epogen. Epogen® (epoetin alfa) injection, for i Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2011-06-24 09:40:12 Growth factors Erythropoietin Epoetin alfa Darbepoetin alfa Anemia Chronic kidney disease Amgen Blood transfusion Adverse effect Medicine Erythropoiesis-stimulating agents Biology
370	FOR IMMEDIATE RELEASE Zyngenia, Inc. Expands Its Board of Directors with Leading Life Sciences Business Executives Christian Itin and Jason Rhodes Gaithersburg, MD, October 11, 2012 – Zyngenia, Inc., a biopharmaceutica Add to Reading List Source URL: www.zyngenia.com Language: English - Date: 2013-06-10 17:55:59 Takeda Pharmaceutical Company Pharmaceutical industry Pharmacy Regulus Therapeutics Amgen CancerVax